![Igor Edouard Fisch](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Igor Edouard Fisch
Fondateur chez Selexis SA
Postes actifs de Igor Edouard Fisch
Sociétés | Poste | Début | Fin |
---|---|---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Directeur/Membre du Conseil | - | - |
Fondateur | 21/01/2010 | - | |
Directeur Général | - | 16/10/2020 | |
Président | 09/03/2001 | - | |
Venturelab AG
![]() Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Corporate Officer/Principal | - | - |
Historique de carrière de Igor Edouard Fisch
Anciens postes connus de Igor Edouard Fisch
Sociétés | Poste | Début | Fin |
---|---|---|---|
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Directeur/Membre du Conseil | 14/07/2011 | - |
Independent Dir/Board Member | 28/04/2011 | - | |
Viroblock SA
![]() Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Directeur/Membre du Conseil | - | 28/07/2009 |
Corporate Officer/Principal | 28/07/2009 | 11/05/2011 |
Formation de Igor Edouard Fisch
University of Cambridge | Doctorate Degree |
Statistiques
Internationale
Suisse | 4 |
Royaume-Uni | 2 |
Danemark | 2 |
Opérationnelle
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorielle
Commercial Services | 3 |
Consumer Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Selexis SA
![]() Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Viroblock SA
![]() Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
Affitech A/S
![]() Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Venturelab AG
![]() Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Finance |
- Bourse
- Insiders
- Igor Edouard Fisch
- Expérience